Broadview Ventures

Broadview Ventures

This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Headquarters Location

United States, Boston


Broadview Ventures is the renowned VC, which was created in 2008. The the headquarters of this VC is in Boston. The fund is located in United States, North America.

The fund usually invests in rounds together with 2-3 others. Besides Broadview Ventures, start-ups are typically funded by Boulder Ventures, Atlas Venture, Amgen Ventures and 2 more VCs. The most common co-investors for the fund are Boulder Ventures, Atlas Venture, Amgen Ventures and also 1 different VC. In subsequent rounds, the fund is usually joined by Remeditex Ventures, Boulder Ventures, Atlas Venture, as well as 8 other investors.

When Broadview Ventures invests, the average start-up valuation is 5-10 millions dollars. In comparison with other funds, Broadview Ventures makes 17 percentage points less than the average number of lead investments. In terms of the fund's performance, this VC has 1 percentage points more exits when compared to other organizations. The fund typically enters into 2-6 deals annually. Deals in the range of 1 - 5 millions dollars are most common for this fund. The highest number of exits from this fund were in 2017. The fund's activity peaked in 2014. Besides, in 2019 the fund was active.

The fund was created by Christopher Colecchi. The overall number of key employees in the fund's team is 6.

Among the most popular portfolio start-ups of the fund, are 480 Biomedical, Capricor Therapeutics, InfoBionic. Among their most successful investment fields, we have identified Therapeutics, Medical Device. Also, because of its portfolio diversification tendency, we can highlight 9 more industries for this fund. The country of its foundation and the country of the most frequent investments for the fund coincides - United States. In addition to this location, the fund participated in 6 other locations. The average start-up age at the time of investment by this fund is 4-5. The fund has no an exact preference in the amount of founders of companies in its portfolio. When a start-up has 4 or 5+ founders, the probability of closing the deal is low.

Year Founded


Fund Activity


Mail Rule [rules by which you can get an email of an interesting for you fund employee, knowing only the name and surname of this employee]

Domain name:; User name format in descending order of probability: first '.' last, first_initial last, first last, last first_initial, first

Group Appearance [how often fund is operating separately from groups with shared interest]

79.3% of cases

Follow-on Index [how often fund is ready to support its portfolio startup at next rounds]

9.1% of cases

Average Multiplicator [the average ratio of the last valuation of portfolio startups to their total amount of financing raised]


Average Portfolio Company
Exit Age [the average age of portfolio startups at which they go public or become acquired]

0.5 years

Success / Strategy Similarity
Index [the matching between fund's investment strategy and its proved successes in the form of portfolio startups high valuations]

0.2 out of 1

Funds Investing in Previous

Boulder Ventures, Atlas Venture, Amgen Ventures

Funds Investing in Following

Remeditex Ventures, Boulder Ventures, Atlas Venture

If you have found a spelling error or the data isn't actual, please, notify us by selecting that text and pressing Ctrl+Enter.

Fund reviews
  • No reviews are submitted yet.
Crunchbase icon

Content report

The following text will be sent to our editors: